Although thrombosis cases are considered very rare, the European Medicines Agency recommends that patients immunized with Oxford/AstraZeneca serum monitor their health within two weeks after vaccination to detect rare but possible symptoms.
serum Oxford/AstraZenecaThe vaccine now called Vaxzevria is one of the four vaccines licensed by the European Union to prevent Coronavirus disease. So far, studies have shown that, despite some cases, it is effective in preventing disease and reducing the risk of hospitalization and death. Two types of low platelet thrombosis Among vaccinated people.
Therefore, the European Medicines Agency (EMA, Because of its English abbreviation) emphasizes the importance of rapid professional medical treatment for the appearance of various symptoms within two weeks after vaccination.
They are from the EMA Pharmacovigilance Committee (wash).
They said: “If the signs of blood clots and low platelets are detected and treated in time, health professionals can help those who recover and avoid complications.”
Therefore, if vaccinated people experience the following symptoms, they should seek medical help immediately: Shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms (E.g. severe and persistent headache or blurred vision) And small blood spots under the skin Beyond the injection site.
He said: “It is very important that health professionals and those who are going to be vaccinated must be aware of these risks and pay attention to the signs or symptoms that may usually appear within two weeks after vaccination.” Sabine Straus, President of PRAC.
In addition, if you have any questions about vaccine implementation in your country/region, EMA also recommends consulting a healthcare professional or contacting the appropriate authorities.